Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/IIa single- and multiple-dose study of IDX320 in healthy volunteers and genotype 1 hepatitis C subjects
NL-OMON35061Phase 1Active, not recruiting
- Sponsor
- Idenix Pharmaceuticals
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of idx320 in hepatitis C virus infection (7 arms), sponsored by Idenix Pharmaceuticals. Primary endpoints: Antiviral activity, Pharmacokinetics and 1 more. Started Jan 2010; status: active, not recruiting.
02
Drugs
idx320
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NL-OMON35061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35061.